High-Throughput Metabolic Engineering: Advances in Small-Molecule Screening and Selection

2010 ◽  
Vol 79 (1) ◽  
pp. 563-590 ◽  
Author(s):  
Jeffrey A. Dietrich ◽  
Adrienne E. McKee ◽  
Jay D. Keasling
2016 ◽  
Vol 113 (11) ◽  
pp. 3018-3023 ◽  
Author(s):  
Samantha G. Pattenden ◽  
Jeremy M. Simon ◽  
Aminah Wali ◽  
Chatura N. Jayakody ◽  
Jacob Troutman ◽  
...  

Mutations in chromatin-modifying proteins and transcription factors are commonly associated with a wide variety of cancers. Through gain- or loss-of-function, these mutations may result in characteristic alterations of accessible chromatin, indicative of shifts in the landscape of regulatory elements genome-wide. The identification of compounds that reverse a specific chromatin signature could lead to chemical probes or potential therapies. To explore whether chromatin accessibility could serve as a platform for small molecule screening, we adapted formaldehyde-assisted isolation of regulatory elements (FAIRE), a chemical method to enrich for nucleosome-depleted genomic regions, as a high-throughput, automated assay. After demonstrating the validity and robustness of this approach, we applied this method to screen an epigenetically targeted small molecule library by evaluating regions of aberrant nucleosome depletion mediated by EWSR1-FLI1, the chimeric transcription factor critical for the bone and soft tissue tumor Ewing sarcoma. As a class, histone deacetylase inhibitors were greatly overrepresented among active compounds. These compounds resulted in diminished accessibility at targeted sites by disrupting transcription of EWSR1-FLI1. Capitalizing on precise differences in chromatin accessibility for drug discovery efforts offers significant advantages because it does not depend on the a priori selection of a single molecular target and may detect novel biologically relevant pathways.


2012 ◽  
Author(s):  
Garth W. Strohbehn ◽  
Jiangbing Zhou ◽  
Michael Fu ◽  
Toral R. Patel ◽  
Joseph M. Piepmeier ◽  
...  

2018 ◽  
Vol 23 (5) ◽  
pp. 448-458
Author(s):  
Bogdan Mazoure ◽  
Iurie Caraus ◽  
Robert Nadon ◽  
Vladimir Makarenkov

Data generated by high-throughput screening (HTS) technologies are prone to spatial bias. Traditionally, bias correction methods used in HTS assume either a simple additive or, more recently, a simple multiplicative spatial bias model. These models do not, however, always provide an accurate correction of measurements in wells located at the intersection of rows and columns affected by spatial bias. The measurements in these wells depend on the nature of interaction between the involved biases. Here, we propose two novel additive and two novel multiplicative spatial bias models accounting for different types of bias interactions. We describe a statistical procedure that allows for detecting and removing different types of additive and multiplicative spatial biases from multiwell plates. We show how this procedure can be applied by analyzing data generated by the four HTS technologies (homogeneous, microorganism, cell-based, and gene expression HTS), the three high-content screening (HCS) technologies (area, intensity, and cell-count HCS), and the only small-molecule microarray technology available in the ChemBank small-molecule screening database. The proposed methods are included in the AssayCorrector program, implemented in R, and available on CRAN.


2005 ◽  
Vol 10 (6) ◽  
pp. 573-580 ◽  
Author(s):  
Neil Benson ◽  
Helen F. Boyd ◽  
Jeremy R. Everett ◽  
Joachim Fries ◽  
Philip Gribbon ◽  
...  

Small molecule screening, the systematic encounter of biology space with chemical space, has provoked the emergence of a whole industry that recreates itself by constant iterative improvements to this process. The authors describe an approach to tackle the problem for one of the most time-consuming steps in the execution of a screening campaign, namely, the reformatting of high-throughput screening test compounds from master plates to daughter assay plates used in the execution of the screen. Through an engineered storage procedure, they prepare plates ahead of the screening process with the respective compounds in a ready-to-use format. They show the biological inertness of the method and how it facilitates efficient recovery of compound activity. This uncoupling of normally interconnected processes provides time and compound savings, avoids repeated freeze-thaw cycles of compound solutions, and removes the problems associated with the DMSO sensitivity of certain assays types.


2020 ◽  
Author(s):  
Adam Pietrobon ◽  
Julien Yockell-Lelievre ◽  
Carole Doré ◽  
Roger Y. Tam ◽  
Sean P. Delaney ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document